Variable | N° of cases | Telomerase activity | P; Chi-square test | |
---|---|---|---|---|
Negative | Positive | |||
Gender | 142 | |||
Female | 12 | 4 | 8 | 0.034 |
Male | 130 | 15 | 115 | |
TNM stage | 142 | |||
I | 86 | 12 | 74 | 0.042 |
II | 9 | 1 | 8 | |
IIIA | 38 | 2 | 36 | |
IIIB | 5 | 2 | 3 | |
IV | 4 | 2 | 2 | |
Size of the primary tumour, T | 142 | |||
T1 | 22 | 3 | 19 | 0.126 |
T2 | 91 | 11 | 80 | |
T3 | 22 | 2 | 20 | |
T4 | 7 | 3 | 4 | |
Lymph node dissemination, N | 142 | |||
N0 | 102 | 13 | 89 | 0.838 |
N1 | 11 | 1 | 10 | |
N2 | 28 | 5 | 23 | |
N3 | 1 | 0 | 1 | |
Tumour metastasis, M | 142 | |||
Absence, M0 | 138 | 17 | 121 | 0.029 |
Presence, M1 | 4 | 2 | 2 | |
Histology | 141a | |||
Squamous cell carcinoma (SCC) | 79 | 8 | 71 | 0.019 |
Adenocarcinoma (AD) | 56 | 7 | 49 | |
Large cell undifferentiated carcinoma (LCUC) | 6 | 3 | 3 |